Search

Your search keyword '"Contarini, Martina"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Contarini, Martina" Remove constraint Author: "Contarini, Martina"
42 results on '"Contarini, Martina"'

Search Results

2. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

4. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

8. Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis.

9. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

10. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

11. Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study

12. Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders.

14. Single Cells RNA Sequencing Reveals that Circulating Hyperinflammatory Monocytes are Associated with Mycobacterium abscessus Pulmonary Disease

17. When and how ruling out cystic fibrosis in adult patients with bronchiectasis

24. Knowledge and attitudes on influenza vaccination among Italian physicians specialized in respiratory infections: an Italian Respiratory Society (SIP/IRS) web-based survey

25. When and how ruling out cystic fibrosis in adult patients with bronchiectasis

26. Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis

28. Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis

29. Respiratory viruses in adults with cystic fibrosis during stable and exacerbations

30. How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis

31. What is the best technique to extract bacterial DNA from sputum?

32. Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation

33. Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire (QoL-B)

34. Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation

35. Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE)

37. Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis

39. An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx)

42. Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE)

Catalog

Books, media, physical & digital resources